Actonel - 0430-0470-15 - (RISEDRONATE SODIUM)

Alphabetical Index


Drug Information of Actonel

Product NDC: 0430-0470
Proprietary Name: Actonel
Non Proprietary Name: RISEDRONATE SODIUM
Active Ingredient(s): 25.8; 4.2    mg/1; mg/1 & nbsp;   RISEDRONATE SODIUM
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Actonel

Product NDC: 0430-0470
Labeler Name: Warner Chilcott (US), LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020835
Marketing Category: NDA
Start Marketing Date: 19980327

Package Information of Actonel

Package NDC: 0430-0470-15
Package Description: 12 BOTTLE in 1 CASE (0430-0470-15) > 30 TABLET, FILM COATED in 1 BOTTLE

NDC Information of Actonel

NDC Code 0430-0470-15
Proprietary Name Actonel
Package Description 12 BOTTLE in 1 CASE (0430-0470-15) > 30 TABLET, FILM COATED in 1 BOTTLE
Product NDC 0430-0470
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name RISEDRONATE SODIUM
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 19980327
Marketing Category Name NDA
Labeler Name Warner Chilcott (US), LLC
Substance Name RISEDRONATE SODIUM HEMI-PENTAHYDRATE; RISEDRONATE SODIUM MONOHYDRATE
Strength Number 25.8; 4.2
Strength Unit mg/1; mg/1
Pharmaceutical Classes Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient],Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient]

Complete Information of Actonel


General Information